Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket

Published 30/05/2023, 13:12
Updated 30/05/2023, 14:40
© Reuters.  Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket

© Reuters. Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
  • Wearable Devices Ltd. (NASDAQ: WLDS) shares rose 33.3% to $1.56 in pre-market trading after dropping 17% on Friday. Wearable Devices recently announced its Mudra Band for Apple Watch is available for preorder.
  • Atento S.A. (NYSE: ATTO) shares surged 26.6% to $1.85 in pre-market trading after gaining 8% on Friday.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) gained 23.8% to $0.26 in pre-market trading after declining over 9% on Friday.
  • Gaotu Techedu Inc. (NYSE: GOTU) shares gained 19.7% to $2.98 in pre-market trading after reporting better-than-expected quarterly sales.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares gained 18.8% to $3.78 in pre-market trading after the company reported the FDA approval of INPEFA for the treatment of heart failure..
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) rose 15.1% to $8.69 in pre-market trading after the company reported the FDA acceptance of the Biologics License Application of lifileucel for the treatment of advanced melanoma.
  • Rigetti Computing, Inc. (NASDAQ: RGTI) rose 14.1% to $1.22 in pre-market trading after jumping 34% on Friday.
  • Recruiter.com Group, Inc. (NASDAQ: RCRT) gained 11.2% to $0.24 in pre-market trading after gaining 8% on Friday. Recruiter.com Group recently reported financial results for its first quarter ended March 31, 2023.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) shares climbed 11% to $0.1050 in pre-market trading after dropping around 11% on Friday. T2 Biosystems recently initiated a process to explore a range of strategic alternatives and a restructuring plan, including a reduction in force.
Losers
  • Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) fell 15.7% to $1.40 in pre-market after gaining around 4% on Friday.
  • Appreciate Holdings, Inc. (NASDAQ: SFR) shares dropped 15.7% to $0.2698 in pre-market trading after jumping around 60% on Friday.
  • IronNet, Inc. (NYSE: IRNT) shares dropped 15.4% to $0.2220 in pre-market trading after climbing 33% on Friday. IronNet 13G Filing showed 3i, LP increased stake in the company to 9.99%.
  • Presto Automation Inc. (NASDAQ: PRST) fell 15.1% to $3.05 in pre-market trading after jumping 64% on Friday. Presto Automation recently entered into commitments for an $10 million common equity pipe.
  • Allarity Therapeutics, Inc. (NASDAQ: ALLR) fell 12.1% to $0.2750 in pre-market trading after declining 9% on Friday.
  • Quhuo Limited (NASDAQ: QH) fell 11.5% to $1.70 in pre-market trading after climbing over 14% on Friday. Quhuo's homestay sector exceeded $1.754 million in sales during Labor Day holiday.
  • Kubient, Inc. (NASDAQ: KBNT) fell 11% to $0.6501 in pre-market trading. Kubient and Adomni recently announced a definitive merger agreement.
  • TScan Therapeutics, Inc. (NASDAQ: TCRX) shares fell 11% to $2.84 in pre-market trading after jumping 31% on Friday. TScan Therapeutics raised $140 million via secondary stock offering of 23 million at $2 per share and 47 million pre-funded warrants at $2 per share.
  • Oncorus, Inc. (NASDAQ: ONCR) fell 10.4% to $0.1967 in pre-market trading after jumping 10% on Friday. Oncorus recently posted a narrower-than-expected quarterly loss.
  • Seelos Therapeutics, Inc. (NASDAQ: SEEL) fell 10.3% to $0.83 in pre-market trading. On May 23, Nasdaq provided notice to Seelos Therapeutics that it has not regained compliance with rule 5550(A)(2).

Now Read This: Investor Optimism Improves Following Rally in US Stocks

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.